Crassus Technology Holdings LLC is a specialized healthcare consulting firm that partners with biotech, pharmaceutical, and medtech companies to facilitate international market expansion — particularly into the Middle East, Balkans, and North Africa.
2000+ people have been consulted and helped
Trusted by 100+ clients around the world. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Step 1
We begin by deeply understanding your business goals, products, and readiness for international expansion. Our team conducts thorough market research to identify the most promising regions for growth—especially in the Middle East, Balkans, and North Africa. Based on our findings, we craft a tailored strategy that aligns with your business objectives and resources.
Step 2
Next, we act as your boots on the ground—sourcing and vetting the right partners, distributors, and stakeholders. We lead negotiations and help you build trusted relationships while guiding you through local compliance, regulatory requirements, and healthcare-specific approvals for biotech, pharma, or medtech products.
Step 3
With the strategy and partnerships in place, we move into action. From launching your market presence to enabling sales teams and customizing local marketing, we drive business development on your behalf. We continue to monitor KPIs, optimize execution, and support long-term growth—operating as your outsourced international expansion team.
Our client-first approach, measurable results, and deep market expertise have earned us long-term partnerships and exceptional satisfaction across the biotech, pharma, and medtech sectors.
Client Satisfaction
Awards Winning
CEO & Founder
Director
Operations Commenced
Unmatched understanding of Middle Eastern and Balkan markets from a U.S. launchpad.
CEO speaks five languages; the team understands local dynamics deeply.
Proven track record (e.g., success with Nano Cures).
Combines retainer + commission, acting as an outsourced international growth team.
Small firm structure, but with expansive international reach.
Trusted Guidance That Feels Like an Extension of Our Team
Crassus Technology Holdings was instrumental in our Middle East expansion. Their market knowledge, regulatory expertise, and strong local ties made the process seamless.
From Planning to Execution—They Deliver.
They bring both strategic depth and hands-on execution. From partner sourcing to market launch, Crassus delivered value at every step.
— Mark Delgado, Chief Strategy Officer, ThermaGenix Inc.
A Strategic Win Beyond Borders
Regulatory Barriers? Solved with Precision.
We struggled with regulatory hurdles for months—until Crassus stepped in. Within weeks, we had clarity, compliance, and a path forward in the MENA region.
Partnerships, Closed Deals, Real Growth
Crassus is not just a consultant—they’re a growth partner. Their results-driven approach and regional fluency helped us close deals we never thought possible.
Fast, Reliable Market Entry with the Right Partners
We were impressed by their professionalism, speed, and results. Crassus helped us break into the Balkans faster than we expected—and with the right partners.
Expanding into international healthcare markets requires more than ambition—it demands strategic insight, local expertise, and trusted guidance. At Crassus Technology Holdings, we specialize in helping biotech, pharmaceutical, and MedTech companies navigate the complex journey of global growth..
We focus exclusively on the healthcare sector—working with biotech, pharmaceutical, and medical technology companies aiming to expand internationally.
Our core focus is on emerging markets, particularly the Middle East, the Balkans, and North Africa. We provide deep regional insight and on-the-ground support.
No. While many of our clients are U.S.-based, we also support companies from the Middle East and other global regions looking to expand their international presence.
We offer a hands-on, execution-driven model. Beyond strategy, we actively facilitate partnerships, navigate regulations, and support implementation—acting as an outsourced international expansion team.
Timelines vary by region and regulatory complexity, but most projects range from 3 to 12 months from initial assessment to launch support.
Timelines vary by region and regulatory complexity, but most projects range from 3 to 12 months from initial assessment to launch support.
Yes. We specialize in helping U.S. startups build early-stage international strategies, including market validation, regulatory planning, and identifying the right entry points for future expansion.
We provide end-to-end support—from customizing market entry strategies and navigating foreign regulations to securing trusted local partners—acting as your outsourced international expansion team.
Partner with Crassus Technology Holdings and take the first step toward strategic international growth. Whether you’re entering the Middle East, Balkans, or North Africa, we’re here to guide you—every step of the way.
Crassus Technology Holdings LLC helps healthcare and medtech companies expand into emerging markets through strategic consulting and business development.
Copyright © 2025 Crassus Technology Holdings LLC, All Rights Reserved